Skip to main content

Forefront Analytics, LLC

SEC CIK
0001696802
Latest filing
Aug 12, 2026

Holdings changes from Q3 2022 to Q4 2022

Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.

Choose two quarters to compare

New
15
Est. +$8.31M
Added
22
Est. +$8.23M
Reduced
35
Est. −$28.4M
Sold out
6
Est. −$753.0K

Portfolio value went from $187.8M to $187.7M (−$119.3K (−0.1%)); positions from 66 to 75 (+9).

All Q4 2022 holdingsAll Q3 2022 holdings

In the shares, value and % of portfolio columns, the top figure is Q4 2022 and the gray one below is Q3 2022. For stocks that split between the two quarters, Q3 2022 shares are converted at the split ratio before comparing.

Holdings of Forefront Analytics, LLC in Q3 2022 and Q4 2022 compared
SecurityActionSharesShare changeValueEst. bought or sold% of portfolioWeight change (pp)
EIGREiger BioPharmaceuticals, Inc.NewHistory12,3790+12,379$14.6K$0+$14.6K<0.1%0.0%+0.01
LONALeonaBio, Inc.NewHistory22,3500+22,350$70.9K$0+$70.9K<0.1%0.0%+0.04
iShares Tr464288513New–3,5790+3,579$263.7K$0+$263.7K0.1%0.0%+0.14
INCYIncyte CorpNewHistory3,3110+3,311$265.9K$0+$265.9K0.1%0.0%+0.14
MDTMedtronic plcNewHistory3,5890+3,589$278.8K$0+$278.8K0.1%0.0%+0.15
iShares Tr46434V647New–12,4310+12,431$282.3K$0+$282.3K0.2%0.0%+0.15
ABTAbbott LaboratoriesNewHistory2,6260+2,626$288.7K$0+$288.7K0.2%0.0%+0.15
iShares Tr464287234New–7,7480+7,748$293.6K$0+$293.6K0.2%0.0%+0.16
Vanguard Emerging Markets Government Bond ETF921946885New–5,7670+5,767$351.6K$0+$351.6K0.2%0.0%+0.19
Schwab U.S. Small-Cap ETF808524607New–9,6120+9,612$389.4K$0+$389.4K0.2%0.0%+0.21
iShares Trust iShares 0-1 Year Treasury Bond ETF464288679New–5,9380+5,938$652.7K$0+$652.7K0.3%0.0%+0.35
iShares Tr464287432New–7,1820+7,182$715.1K$0+$715.1K0.4%0.0%+0.38
Invesco Exch TRD SLF Idx FD46138J460New–49,0410+49,041$783.0K$0+$783.0K0.4%0.0%+0.42
State Street Real Estate Select Sector SPDR ETF81369Y860New–29,2410+29,241$1.08M$0+$1.08M0.6%0.0%+0.58
Invesco Exchange Traded FD T46137V837New–36,3520+36,352$2.58M$0+$2.58M1.4%0.0%+1.38

Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.